Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2016-02-29 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a short announcement (840 characters) dated February 29, 2016, titled 'Blue Vision A/S indgår en market maker aftale med Københavns Andelskasse' (Blue Vision A/S enters into a market maker agreement with Københavns Andelskasse). This agreement concerns the continuous provision of two-way prices for the company's shares on Nasdaq Copenhagen. This type of announcement, detailing a specific operational or market-related agreement that affects trading, does not fit neatly into the primary financial reporting categories (10-K, IR, ER). It is a specific corporate action/regulatory event announcement. Since it is not a director's dealing, dividend notice, capital change, or M&A, the most appropriate fallback category for a specific, non-standard regulatory announcement is 'Regulatory Filings' (RNS).
2016-02-29 English
Regulatory Filings 2016
Regulatory Filings Classification · 97% confidence The document is very short (736 characters) and announces a new 'market maker agreement' (market maker aftale) between Blue Vision A/S and Københavns Andelskasse for providing continuous two-way pricing on the company's shares on Nasdaq Copenhagen. This is a specific operational announcement related to market liquidity and trading arrangements. It does not fit the definitions for Annual Report (10-K), Earnings Release (ER), Dividend Notice (DIV), or Director's Dealing (DIRS). Since it is a specific regulatory/market-related announcement that doesn't fit the other precise categories (like CAP, CT, or MANG), the most appropriate general category for specific, non-standard regulatory or market updates is 'Regulatory Filings' (RNS), as it is a formal notice to the market about a change in trading support mechanisms.
2016-02-29 Danish
Blue Vision A/S gennemfører aktiesplit
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Blue Vision A/S regarding a stock split (aktiesplit). It details the change in nominal share value, the new share count, the new ISIN code, and the implementation timeline. This falls directly under the category of share capital changes or stock splits.
2016-02-18 English
Blue Vision A/S gennemfører aktiesplit
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement informing shareholders of a share split (each DKK10 share being split into 10 shares of DKK1), including details of the new ISIN code and implementation timetable. This is a capital change (share split), which falls under the “Share Issue/Capital Change” category (SHA).
2016-02-18 Danish
Board/Management Information 2016
Board/Management Information Classification · 99% confidence The document text is a formal announcement from Blue Vision A/S dated February 18, 2016, detailing a change in the Board of Directors. Specifically, it states that Leif Erlandsen is resigning as Chairman of the Board and Niels Troen has been elected to replace him following an extraordinary general meeting. This content directly relates to changes in the company's senior leadership and board composition. This matches the definition for Board/Management Information (MANG). The document length (4158 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2016-02-18 English
Board/Management Information 2016
Board/Management Information Classification · 99% confidence The document text is a formal announcement in Danish regarding a change in the Board of Directors. Specifically, it states that Leif Erlandsen is resigning as Chairman of the Board ('bestyrelsesformand') and that Niels Troen has been elected as the new Chairman at an extraordinary general meeting ('ekstraordinære generalforsamling'). It details the background and previous roles of the new chairman. This content directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2016-02-18 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.